A Combined Human <i>in Silico</i> and CRISPR/Cas9-Mediated <i>in Vivo</i> Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.

Front Pharmacol · 2022 · PMC9082939 · PMID 35548346

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

borderline significantp -value = 9 × 10 −7actually significant

Assessment of API5 revealed a significant association with body mass index (BMI) and a borderline significant association with neutrophil count ( p -value = 9 × 10 −7 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

A Combined Human &lt;i&gt;in Silico&lt;/i&gt; and CRISPR/Cas9-Mediated &lt;i&gt;in Vivo&lt;/i&gt; Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.

The sentences

A Combined Human <i>in Silico</i> and CRISPR/Cas9-Mediated <i>in Vivo</i> Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation.